Does the neuroprotective agent Erythropoietin amplify diffuse axonal injury in its early stages?

R. Shane Tubbs; Mohammadali Mohajel Shoja; Masoud Jamshidi; Ghaffar Shokouhi

doi:10.1016/j.mehy.2007.03.002

Does the neuroprotective agent Erythropoietin amplify diffuse axonal injury in its early stages?

R. Shane Tubbs, Mohammadali Mohajel Shoja, Masoud Jamshidi, Ghaffar Shokouhi

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	1385-1386
Number of pages	2
Journal	Medical Hypotheses
Volume	69
Issue number	6
DOIs	https://doi.org/10.1016/j.mehy.2007.03.002
State	Published - Oct 30 2007
Externally published	Yes

ASJC Scopus subject areas

Developmental Biology
Medicine(all)
Drug Discovery

Access to Document

10.1016/j.mehy.2007.03.002

Cite this

@article{498ab214932546fc8555c18a9712ff62,

title = "Does the neuroprotective agent Erythropoietin amplify diffuse axonal injury in its early stages?",

author = "Tubbs, {R. Shane} and {Mohajel Shoja}, Mohammadali and Masoud Jamshidi and Ghaffar Shokouhi",

year = "2007",

month = oct,

day = "30",

doi = "10.1016/j.mehy.2007.03.002",

language = "English (US)",

volume = "69",

pages = "1385--1386",

journal = "Medical Hypotheses",

issn = "0306-9877",